PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.